Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEXTNRG, INC. Director's Dealing 2021

Dec 6, 2021

33541_dirs_2021-12-06_d0223726-ed0b-4ea2-8adf-7fa0e313f0f1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EzFill Holdings Inc (EZFL)
CIK: 0001817004
Period of Report: 2021-12-02

Reporting Person: LEVINE JACK (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-02 Common Stock P 20263 $2.25 Acquired 94026 Direct
2021-12-02 Common Stock P 254 $2.24 Acquired 94280 Direct
2021-12-02 Common Stock P 1523 $2.28 Acquired 95803 Direct
2021-12-03 Common Stock P 18000 $2.18 Acquired 113803 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 186010 Indirect

Footnotes

F1: The 20,263 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife.

F2: The 254 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife.

F3: The 1,523 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife.

F4: The 18,000 shares the Reporting Person purchased on December 3, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife.

F5: Jack Levine is the Manager of Cameo Life Sciences Investments LLC and beneficially owns 186,010 shares of common stock, which are held by Cameo Life Sciences Investments, LLC.